Effects of a supportive German online program for people with depression or adjustment
Not Applicable
Completed
- Conditions
- Mild depressive episode, Moderate depressive episode, Recurrent depressive disorder, current episode mild, Recurrent depressive disorder, current episode moderate, Dysthymia, Adjustment disordersMental and Behavioural DisordersMild depressive episode
- Registration Number
- ISRCTN02446836
- Lead Sponsor
- Bank (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 608
Inclusion Criteria
1. The target group consists of insurants of the commercial insurance KKH with a principal diagnosis of mood disorders (F32.0, F32.1, F33.0, F33.1 and F34.1) or adjustment disorder (F43.2) at an age between 18 to 65 years, either sex.
2. Current incapacity to work certificate and an Internet access/e-mail account
Exclusion Criteria
1. Presence of severe depression
2. Risk of suicide (dedicated collection of active and passive suicidal tendencies)
3. Missing declaration of consent (informed consent)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of online cognitive behavioral therapy in treating mild to moderate depression and adjustment disorders as studied in ISRCTN02446836?
How does the German online program in ISRCTN02446836 compare to standard-of-care antidepressants like SSRIs in treating recurrent depressive disorder and dysthymia?
What biomarkers are associated with response prediction to digital mental health interventions in patients with adjustment disorders and depressive episodes as per ISRCTN02446836?
What adverse events are reported in ISRCTN02446836's online intervention for depression and how are they managed compared to traditional therapies?
What combination approaches or competitor drugs are being evaluated alongside digital programs for mild/moderate depression in Germany, as related to ISRCTN02446836's therapeutic landscape?